Characteristics of patients diagnosed with psoriasis and psoriatic arthritis
Keywords:
autoimmune diseases, psoriasis, psoriasic arthritis, spondyloarthropathiesAbstract
Introduction: Psoriasis and psoriatic arthropathy are autoimmune diseases whose sustained clinical activity affects the health status of patients; hence the importance of its control.
Objective: To describe the results of a therapeutic intervention with multidisciplinary management of patients with psoriasis and psoriatic arthritis.
Methods: Applied research was carried out, with a series of 47 cases with a diagnosis of psoriasis and psoriatic arthritis. Multidisciplinary management was carried out by a specialist in dermatology and rheumatology, with 12-month follow-up for each patient. The intensity of joint pain, the presence of dermatological manifestations and other manifestations as part of the symptomatology of the disease were evaluated as variables.
Results: Average age less than 45 years in both conditions, female patients predominated in both psoriasis (71.43%) and psoriatic arthritis (73.68%). 57.89% of patients with psoriatic arthritis and 42.86% of patients with psoriasis had at least one associated comorbidity. High blood pressure, hypothyroidism and diabetes mellitus were the most frequently reported comorbidities in both groups of people. At the beginning of the study, moderate clinical activity of both diseases was identified in 40.42% of cases.
Conclusions: Multidisciplinary management of patients with psoriasis and psoriatic arthritis is essential to improve the control of clinical activity of patients with psoriasis and psoriatic arthritis; conditions an increase in the percentage of patients with disease remission and mild/low clinical activity.
Downloads
References
Solis-Cartas U, Hernández-Batista S, Rodríguez-Moldón Y, Expósito-Lara A. Enfermedades reumáticas e inmunosupresión, mitos y realidades desde la perspectiva etiopatogénica de la enfermedad [Internet]. Rev Cuba Reumatol. 2022 [acceso: 17/06/2024]; 24(3):e1321. Disponible en: https://revreumatologia.sld.cu/index.php/reumatologia/article/view/1019
Cazar Chávez MJ, Pino Falconí PE, Moya Romero KS, Muñiz Vásquez VA. Nuevo panorama para las enfermedades reumáticas pediátricas [Internet]. Rev Cuba Reumatol. 2022 [acceso: 19/06/2024]; 24(2):34-43. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962022000200006&lng=es
Ibáñez S, Valenzuela F, Valenzuela O. Artritis psoriásica: La elección del fármaco antirreumático biológico en la Ley Ricarte Soto [Internet]. Rev méd Chile. 2020 [acceso: 22/06/2024]; 148(5):657-64. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000500657&lng=es
Casas Figueredo N, Yánez Paredes ET, Estévez del Toro MH, Argüelles Zayas A, Sánchez Bruzón Y, Chico Capote A. Factores de riesgo cardiovascular en pacientes con artritis psoriásica [Internet]. Rev Cuban de Med. 2023 [acceso: 25/06/2024]; 62(3):e247. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232023000300010&lng=es
Academia Española de Dermatología y venereología (AEDV). ¿CÓMO SE MIDE LA GRAVEDAD DE LA PSORIASIS? Principales índices [Internet]. 2016 [acceso: 19/06/2024]. Disponible en: https://aedv.es/wp-content/uploads/2016/07/Indices-de-medicio%CC%81n-de-psoriasis.pdf
Castro Coello V, López Martínez R, González Guzmán M, Moreno Álvarez M. Valoración de la actividad de artritis psoriásica a través del índice DAPSA (disease activity for psoriatic arthritis) [Internet]. RevReumDia. 2017 [acceso: 21/06/2024];13(1):[aprox. 5 pant.]. Disponible en: https://reumatologiaaldia.com/index.php/rad/article/view/2952
Legarda Urgilés EM, Palacios Legarda AN. Artritis reumática juvenil idiopática: características y criterios diagnósticos [Internet]. Rev Cuba Reumatol. 2022 [acceso: 22/06/2024]; 24(1):121-34. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962022000100009&lng=es
Carrizo Abarza V, Isnardi Carolina A, Schneeberger EE, Barbich T, Luna G, Dapeña JM, et al. Impacto de la presencia de depresión y ansiedad en pacientes con artritis psoriásica [Internet]. Rev argent reumatolg. 2022 [acceso: 20/06/2024]; 33(2):52-66. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S2362-36752022000200052&lng=es
Hyun Ji L, Miri K. Retos y tendencias futuras en el tratamiento de la psoriasis [Internet]. J Mol Ciencia. 2023; 24(17):13313. DOI: 10.3390/ijms241713313
Sarobe M, Arrondo A, Ibarrondo O, Mar J. Calidad de vida relacionada con la salud en pacientes con artritis reumatoide, artritis psoriásica y espondilitis anquilosante tratados con certolizumab pegol [Internet]. Farm Hosp. 2022 [acceso: 23/06/2024]; 46(1):27-30. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432022000100027&lng=es
Hernández Castro JL, Casas Figueredo N, Tamargo Barbeito TO, Hernández Castillo AR. Caracterización ultrasonográfica del daño articular en rodilla para evaluación de las espondiloartropatías [Internet]. Rev cubana med. 2022 [acceso: 18/06/2024]; 61(1):29-43. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232022000100010&lng=es
Solis Cartas U, Calvopiña Bejarano SJ. Comorbilidades y calidad de vida en Osteoartritis [Internet]. Rev Cuba Reumatol. 2018 [acceso: 23/06/2024]; 20(2):107-16. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962018000200002&lng=es
Cando Ger AE, Valencia Catacta EE, Segovia Torres GA, Tutillo León JA, Paucar Tipantuña LE, Zambrano Carrión MC. Avances en la atención de salud a los pacientes con enfermedades reumáticas [Internet]. Rev Cuba Reumatol. 2018 [acceso: 21/06/2024]; 20(3):e1132. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962018000300004&lng=es
Solis Cartas U, Martínez Larrarte JP. Opciones terapéuticas al síndrome de liberación de citoquinas en pacientes con COVID-19 [Internet]. Rev Cub Med Mil. 2020 [acceso: 19/06/2024]; 49(3):e0200783. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572020000300022&lng=es
Queiro R, Coto P, Rodríguez J, Notario J, Navío T, de la Cueva P, et al. Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España [Internet]. Reumatología clínica 2017 [acceso: 20/06/2024];13(2):85-90. Disponible en: https://www.reumatologiaclinica.org/es-modelos-atencion-multidisciplinar-pacientes-con-articulo-S1699258X16000498
Queiro R, Coto P, Joven B, Rivera R, Navío T, de la Cueva P, et al. Estado actual de la atención multidisciplinar para pacientes con artritis psoriásica en España: proyecto NEXUS 2.0 [Internet]. Reumatología clínica 2022 [acceso: 17/06/2024];16(1):24-31. Disponible en: https://www.reumatologiaclinica.org/es-estado-actual-atencion-multidisciplinar-pacientes-articulo-S1699258X18300305
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jessica Magali Herrera Abarca, Luis Medardo Jara Orna, Jhia Vanessa Navarrete Veloz, José Andrés Zaporta Ramos
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.
